Pharmaceutical Sciences Assistant Professor Zhaokang Cheng and Postdoctoral Research Associate Peng Xia with six co-authors published, “Genome-wide RNAi screen identifies regulators of cardiomyocyte necrosis,” in ACS Pharmacology & Translational Science, a peer-reviewed open-access journal from the American Chemical Society in September 2019. View abstract »
Pharmaceutical Sciences Associate in Research Christy J.W. Watson, Pharmaceutical Sciences Professor and Chair Philip Lazarus, Pharmaceutical Sciences Assistant Professor Travis T. Denton and six co-authors published, “The novel CYP2A6 inhibitor, DLCI-1, decreases nicotine self-administration in mice,” in the peer-reviewed The Journal of Pharmacology and Experimental Therapeutics in October 2019. View abstract »
Allen I. White Distinguished Associate Professor Joshua Neumiller and one co-author published, “How does CREDENCE inform best use of SGLT2 inhibitors in CKD?” in the CJASN, an official publication of the American Society of Nephrology in October 2019. Read article »
Josh Neumiller and one co-author published, “Oral semaglutide: a new GLP-1 receptor agonist product for the treatment of type 2 diabetes,” in the U.S. Pharmacist in October 2019. Read article »
J. Roberts and Marcia Fosberg Distinguished Professor Daniel Baker published, “Drug evaluation – polatuzumab vedotin-piiq (POLIVY),” in Wolters Kluwer Health’s The Formulary Monograph Service (FMS) in September 2019. Wolters Kluwer Health is a drug and health information publisher, the FMS is a resource used in the formulary decision making process for hospitals and managed care systems on recently released and investigational drugs.
Daniel Baker published, “Drug evaluation – upadacitinib: preliminary evaluation,” in the FMS in September 2019.
Pharmacotherapy Research Associate Jessie Dinh and Daniel Baker published, “Drug evaluation – fedratinib: preliminary evaluation,” in the FMS in September 2019.
Pharmacotherapy Clinical Professor Terri Levien and Daniel Baker published, “Drug evaluation – bremelanotide (Vyleesi),” in the FMS in September 2019.
Terri Levien and Daniel Baker published, “Drug evaluation -imipenem/cilastatin/relebactam (Recarbrio),” in the FMS in September 2019.
Daniel Baker published, “Drug utilization evaluation – imipenem/cilastatin/relebactam,” in the FMS in September 2019.
Pharmacotherapy Clinical Assistant Professor (Yakima) Damianne Brand-Eubanks published, “Gvoke HypoPen: an auto-injector containing an innovative, liquid-stable glucagon formulation for use in severe acute hypoglycemia,” in Clinical Diabetes, a peer-reviewed journal by the American Diabetes Association, in October 2019. View abstract »
Pharmacotherapy Clinical Assistant Professor (Yakima) Matthew Thomas with three co-authors published, “The effect of heparin infusion intensity on outcomes for bridging hospitalized patients with a trial fibrillation,“ in Clinical Cardiology in September 2019. Read article »
Danial Baker presented, “Immunological agents,” at the United States Pharmacopeia (USP) DC Expert Panel – Working Group Meeting in Rockville, Maryland on September 5, 2019.
Danial Baker presented, “Preparing pharmacists for practice in 2035,” at the Symposium on Advances in Pharmacy Practice: USA & UAE Perspectives at the Gulf Medical University in Ajman, United Arab Emirates on September 22, 2019.
Damianne Brand-Eubanks and Pharmacotherapy Research Associate (Yakima) Emily Darst gave the oral presentation, “The pharmacy compounding lab as a destination for student-led interprofessional education and personalized medicine,” at the Collaborating Across Borders Conference (CAB). CAB is an international conference focused on interprofessional education that is hosted every two years between the US and Canada. Their presentation focused on the interprofessional cocurricular collaborative experience that we have been developing between our Yakima Compounding Club pharmacy students and the Doctor of Osteopathic Medicine students in the Dermatology Club at PNWU. The collaboration is a student-developed and student-taught experience, which gives students wonderful opportunities to develop leadership skills and practice provider education. They have hosted this experience between the two programs for 4 consecutive semesters.
Emily Darst will give a talk about the new USP <800> guidelines (Hazardous Drugs – Handling in Healthcare Settings), as well as recent revisions to the USP <795> (Pharmaceutical Compounding – Nonsterile Preparations) and <797> guidelines (Pharmaceutical Compounding – Sterile Preparations) at the upcoming WSPA Annual Meeting in Cle Elum on November 9. The presentation will qualify for pharmacist Continuing Education credit for those that would like to attend!
Danial Baker received the Thomas S. Foster Award from USP. This award recognizes his dedication and significant contributions to the achievement of USP standards-setting priorities or the improvement of USP’s standards-setting processes in a specific area within the EC portfolio.
Zhaokang Cheng received $449,098 from the National Heart, Lung, and Blood Institute for a research project titled, “Mechanisms of cardiac chemosensitivity.”
Doctor of Philosophy (Ph.D) students
Panshak Dakup (pharmaceutical sciences, Gaddameedhi lab) presented the poster and invited talk, “Circadian clock disruption impairs the skin’s DNA damage response to solar UVB and increases mutagenicity,” to the DNA repair Special Interest Group of the Environmental Mutagenesis and Genomics Society on September 20, 2019. Co-authors on the poster include Pharmaceutical Sciences Research Technologist Kenneth Porter, Pharmaceutical Sciences Assistant Professor Shobhan Gaddameedhi and Rajendra Gajula.
Soumyadeep Sarkar and Panshak Dakup (pharmaceutical sciences, Gaddameedhi lab) and faculty co-authors Kenneth Porter and Shobhan Gaddameedhi with Rajendra P. Gajula gave an oral and poster presentation on “Circadian clock protein BMAL1 regulates melanin synthesis through MITF,” for the PanAmerican Society for Pigment Cell Research (PASPCR) 2019 meeting in Bar Harbor, Maine on October 2, 2019.
Jing Wang (Denton lab, Pharm.D. Honors Student) with faculty co-authors Christy J.W. Watson, Philip Lazarus, Travis T. Denton and five other authors published “The novel CYP2A6 inhibitor, DLCI-1, decreases nicotine self-administration in mice,” in the peer-reviewed The Journal of Pharmacology and Experimental Therapeutics in October 2019. View abstract »
Madalyn Brown (pharmaceutical sciences, Gibson/Roullet labs) presented the poster, “Detection of succinic semialdehyde dehydrogenase deficiency in newborn dried blood spots,” at the American Society of Human Genetics Annual Meeting in Houston, Texas on October 17, 2019. This abstract scored in the top 10% and received Reviewers’ Choice designation.
Madalyn Brown presented the poster, “Novel detection of succinic semialdehyde dehydrogenase deficiency (SSADHD) in newborn dried blood spots,” at the National Organization for Rare Disorders Annual Summit in Washington, D.C. on October 21, 2019. Madalyn received a travel award to present the poster.
Panshak Dakup received a $750 merit-based Alexander Hollaender travel award from the Environmental Mutagenesis and Genomics Society to attend the annual meeting in Washington D.C. In addition, he received $500 from the WSU College of Pharmacy and Pharmaceutical Sciences (CPPS) Department of Pharmaceutical Sciences.
Soumyadeep Sarkar won second place in poster competition at PASPCR 2019.
Soumyadeep Sarkar received a $700 travel award from PASPCR.
Soumyadeep Sarkar received a $500 travel award from the CPPS Sue Harriet Monroe Mullen Graduate Fellowship.
Doctor of Pharmacy (Pharm.D.) students
Connor Smith with faculty co-author Josh Neumiller published, “Oral semaglutide: a new GLP-1 receptor agonist product for the treatment of type 2 diabetes,” in the U.S. Pharmacist in October 2019. Read article »